Conclusions
The new era of HIV treatment offered by protease inhibitors and combination therapies offers great hope and great challenges. Mental health providers, now as much as ever, are well positioned to aid in the care of people living with HIV infection. To remain optimally effective, caregivers must be well informed about the progression of HIV infection and the progress of medical science in battling AIDS, as well as their potential psychological and behavioral downsides. Protease inhibitors are the most recent of what is hoped will be many new HIV treatments that will bring new challenges to the care of clients living with HIV and AIDS.
Keywords
- Human Immunodeficiency Virus
- Human Immunodeficiency Virus Infection
- Unprotected Anal Intercourse
- Human Immunodeficiency Virus Disease
- Human Immunodeficiency Virus Transmission
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Besch, C. L. (1995). Compliance in clinical trials. AIDS, 9, 1–10
Carey, M. P., & Burish, T. G. (1988). Etiology and treatment of the psychological side effects associated with cancer chemotherapy: A critical review and discussion. Psychological Bulletin, 104, 307–325.
Cohen, J. (1997). Advances painted in shades of gray at a D. C. conference. Science, 275, 615–616.
Deeks, S. G., Smith, M., Holodniy, M., & Kahn, J. (1997). HIV-1 protease inhibitors: A review for clinicians. Journal of the American Medical Association, 277, 145–153.
Dilley, J. W., Woods, W. J., & McFarland, W. (1997). Are advances in treatment changing views about high-risk sex? [Letter]. New England Journal of Medicine, 337, 501–502.
Eller, L. S. (1995). Effects of two congitive-behavioral interventions on immunity and symptoms in persons with HIV. Annals of Behavioral Medicine, 17, 330–348.
Fatkenheurer, G., Theisen, A., Rockstroh, J., Grabow, T., Wicke, C., Becker, K., Wieland, U., Pfister, H., Reiser, M., Hegener, P., Franzen, C., Schwenk, A., & Salzberger, B. (1997). Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS, 11, F113–F116.
Gendin, S. (1997, June). Riding bareback: Skin-on-skin sex—Been there, done that, want more. Poz Magazine, pp. 64–65.
Ho, D. D. (1995). Time to hit HIV, early and hard. New England Journal of Medicine, 333 (7), 450–451.
Ho, D. D. (1996). Therapy of HIV infections: Problems and prospects. Bulletin of the New York Acad of Medicine, 73 (1), 37–45.
Holland, J. (1982). Psychological aspects of cancer. In J. Holland & E. Frei (Eds.), Cancer and medicine (2nd ed., pp. 1175–1203), Philadelphia: Lea & Febiger.
Kalichman, S. C. (1995). Understanding AIDS: A guide for mental health professionals. Washington, DC: American Psychological Association.
Kalichman, S. C. (1997). AIDS treatment advances and behavioral prevention setbacks: lmplications of reduced threat perceptions. Manuscript submitted for publication.
Kalichman, S. C. (1998a, August). Preventing AIDS: Part, present, and future contributions from psychology. Paper presented at the convention of the American Psychological Association, San Francisco.
Kalichman, S. C. (1998b). Preventing AIDS: A source book for behavioral interventions. Mahwah, NJ: Erlbaum.
Kalichman, S. C., (1998c). Post-exposure prophylaxis for HIV infection in gay and bisexual men: Implications for the future HIV prevention. American Journal of Preventive Medicine, 15, 120–127.
Kalichman, S. C., Carey, M. P., & Johnson, B. T. (1996). Prevention of sexually transmitted HIV infection: Meta-analytic review and critique of the theory-based intervention outcome literature. Annals of Behavioral Medicine, 18, 6–15.
Kalichman, S. C., Kelly, J. A., & Rompa, D. (1997). Continued high-risk sex among HIV seropositive men. Health Psychology, 16, 369–373.
Kalichman, S. C., Roffman, R., & Picciano, J. (1997). Sexual relationships and sexual risk behaviors among human immunodeficiency virus (HIV) seropositive gay and bisexual men seeking risk reduction services. Professional Psychology: Research and Practice, 28, 355–360.
Kalichman, S. C., Ramachandran, B., & Ostrow, D. G. (1998). Protease inhibitors and the new AIDS combination therapies: Implications for psychological services. Submitted for publication.
Kelly, J. A., Murphy, D. A., Bahr, G. R., Kalichman, S. C., Morgan, M. G., Stevenson, L. Y., Koob, J. J., Brasfield, T. L., & Bernstein, B. M. (1993). Outcome ofcognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. American Journal of Psychiatry. 150, 1679–1986.
Kitahata, M. M., Koepsell, T. D., Deyo, R. A., Maxwell, C. L., Dodge, W. T., & Wagner, E. H. (1996). Physician’s experience with the acquired immunodefieiency syndrome as a factor in patients’survival. The New England Journal of Medicine, 334, 701–706.
Laperriere, A. R., Antoni, M. H., Schneiderman, N., Ironson, G., Klimas, N., Cadis, P., & Fletcher, M. D. (1990). Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback and Self-Regulation, 15, 229–242.
Markowitz, J. C., Klerman, G. L., Claugherty, K. F., Spielman, L. A., Jacobsberg, L. B., Fishman, B., Frances, A. J., Koesis, J. H., & Perry, S. W. (1995). Individual psychotherapies for depressed HlV-positive patients. American Journal of Psychiatry, 152, 1504–1509.
Miller, S. (1987). Monitoring and blunting: Validation of a questionnaire to assess styles of information seeking under threat. Journal of Personality and Social Psychology, 52, 345–353.
Miller, S., & Mangan, C. E. (1983). Interacting effects of information and coping styles in adapting to gynecologic stress: Should the doctor tell all? Journal of Personality and Social Psychology, 45, 223–236.
Miller, S., Brody, D., & Summerton, J. (1988). Styles of coping with threat: Implications for health. Journal of Personality and Social Psychology, 53, 142–148.
Rabkin, J. G., & Ferrando, S. (1997). A “second life” agenda: Psychiatric research issues raised by protease inhibitor treatments for people with human immunodeficiency virus or the acquired immunodeficiency syndrome. Archives of General Psychiatry, 54, 1049–1053.
Rabkin, J. G., Remien, R., Katoff, L., & Williams, J. (1993). Resiliency in adversity among long-term survivors ifAIDS. Hospital and Community Psychology, 44, 162–167.
Reed, G. M., Kemeny, M. E., Taylor, S. E., Wang, H.-Y. J., & Visscher, B. R. (1994). “Realistic acceptance” as a predictor of survival time in gay men with AIDS. Health Psychology, 13, 299–307.
Remien, R. H., Rabkin, J., Williams, J., Katoff, L. (1992). Coping strategies and health beliefs of AIDS longterm survivors. Psychology and Health, 6, 335–345.
Sikkema, K. & Kelly, J. (1996). Behavioral medicine interventions can improve quality of life and health of persons with HIV disease. Annals of Behavioral Medicine, 18, 40–48.
Sullivan, A. (1997, November 10). When AIDS ends. New York Times Magazine, pp. 52–84.
Vernazza, P. L., Gillian, B., Dyer, M., Fiscus, S., Eron, J., Frank, A., & Cohen, M. (1997). Quantification of HIV in semen: Correlation with antiretroviral treatment and immune status. AIDS, 11, 987–993.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Kalichman, S.C., Ramachandran, B. (2002). Mental Health Implications of New HIV Treatments. In: Ostrow, D.G., Kalichman, S.C. (eds) Psychosocial and Public Health Impacts of New HIV Therapies. AIDS Prevention and Mental Health. Springer, Boston, MA. https://doi.org/10.1007/0-306-47159-0_6
Download citation
DOI: https://doi.org/10.1007/0-306-47159-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45973-3
Online ISBN: 978-0-306-47159-9
eBook Packages: Springer Book Archive